-+ 0.00%
-+ 0.00%
-+ 0.00%

UPDATE 1-Kakitangan FDA AS menimbulkan kebimbangan keberkesanan terhadap ubat kanser kulit Replimune sebelum mesyuarat

Reuters·07/28/2026 12:01:36